|
血清胱抑素C对肾脏病诊断的价值
|
Abstract:
[1] | Zi, M. and Xu, Y. (2018) Involvement of Cystatin C in Immunity and Apoptosis. Immunology Letters, 196, 80-90.
https://doi.org/10.1016/j.imlet.2018.01.006 |
[2] | Kar, S., Paglialunga, S. and Islam, R. (2018) Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies. Journal of Clinical Pharmacology, 58, 1239-1247. https://doi.org/10.1002/jcph.1132 |
[3] | 刘宁, 成金钟, 陈亚巍. 测定慢性肾小球肾炎患者血清胱抑素C水平的变化及意义[J]. 中华保健医学杂志, 2012, 14(2): 150-152. |
[4] | 赵帆, 张枚, 何訸, 等. 糖尿病肾病患者血清胱抑素C和尿微量白蛋白检测水平分析[J]. 中国实验诊断学, 2018, 22(10): 1711-1714. |
[5] | Satirapoj, B. (2018) Tubulointerstitial Biomarkers for Diabetic Nephropathy. Journal of Diabetes Research, 2018, Article ID: 2852398. https://doi.org/10.1155/2018/2852398 |
[6] | Elsayed, M.S., El Badawy, A., Ahmed, A., et al. (2019) Serum Cystatin C as an Indicator for Early Detection of Diabetic Nephropathy in Type 2 Diabetes Mellitus. Diabetes & Metabolic Syndrome, 13, 374-381.
https://doi.org/10.1016/j.dsx.2018.08.017 |
[7] | 杨建宝, 李金巍. 高血压肾病患者的中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C、肌酐、尿素氮水平及其临床意义研究[J]. 中国临床医生杂志, 2018, 46(4): 408-410. |
[8] | 蒋琰, 刘如石, 李原, 等. 血清胱抑素C、同型半胱氨酸联合检测对诊断高血压早期肾病的意义[J]. 重庆医学, 2015, 44(9): 1193-1196. |
[9] | Bhavsar, N.A., Appel, L.J., Kusek, J.W., et al. (2011) Comparison of Measured GFR, Serum Creatinine, Cystatin C, and Beta-Trace Protein to Predict ESRD in African Americans with Hypertensive CKD. American Journal of Kidney Diseases, 58, 886-893. https://doi.org/10.1053/j.ajkd.2011.07.018 |
[10] | Naito, Y., Sawada, H., Oboshi, M., et al. (2013) Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats. PLoS ONE, 8, e75906. https://doi.org/10.1371/journal.pone.0075906 |
[11] | Tylicki, L. and Rutkowski, B. (2003) Hypertensive Nephropathy: Pathogenesis, Diagnosis and Treatment. Polski merkuriusz lekarski: Organ Polskiego Towarzystwa Lekarskiego, 14, 168-173. |
[12] | Wali, U., Hussain, M.M., Wali, N., et al. (2019) Comparison of Serum Levels of Cystatin-C and Traditional Renal Biomarkers for the Early Detection of Pre-Hypertensive Nephropathy. Journal of Pakistan Medical Association, 69, 313-319. |
[13] | 武敏, 黄传兵, 贾建云, 等. 胱抑素C在系统性红斑狼疮肾损害中的研究概况[J]. 中医药临床杂志, 2015, 27(1): 17-20. |
[14] | 赵秀芬, 黄智敏, 钱军, 等. 血清胱抑素C与IgA肾病Lee氏病理分级的相关性[J]. 江苏医药, 2016, 42(23): 2553-2555. |
[15] | 向莉, 周华, 李旻, 等. 胱抑素C评估IgA肾病患者肾纤维化程度及早期肾损害的价值[J]. 江苏医药, 2012, 38(16): 1899-1901. |
[16] | Peixoto, L., Aguiar, P., de Braganca, R., et al. (2015) Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus? Acta Médica Portuguesa, 28, 333-341. https://doi.org/10.20344/amp.5770 |
[17] | Kokkoris, S., Pipili, C., Grapsa, E., et al. (2013) Novel Biomarkers of Acute Kidney Injury in the General Adult ICU: A Review. Renal Failure, 35, 579-591. https://doi.org/10.3109/0886022X.2013.773835 |
[18] | Fouad, M. and Boraie, M. (2013) Cystatin C as an Early Marker of Acute Kidney Injury and Predictor of Mortality in the Intensive Care Unit after Acute Myocardial Infarction. Arab Journal of Nephrology and Transplantation, 6, 21-26. |
[19] | Leem, A.Y., Park, M.S., Park, B.H., et al. (2017) Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery. Yonsei Medical Journal, 58, 604-612.
https://doi.org/10.3349/ymj.2017.58.3.604 |
[20] | Beker, B.M., Corleto, M.G., Fieiras, C., et al. (2018) Novel Acute Kidney Injury Biomarkers: Their Characteristics, Utility and Concerns. International Urology and Nephrology, 50, 705-713. https://doi.org/10.1007/s11255-017-1781-x |